Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Presas-Rodríguez

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Neurologia|December 25, 2021
Catastrophic demyelinating multifocal encephalitisS Rubio-Guerra, A Massuet-Vilamajó, S Presas-Rodríguez, et al.
Neurologia|April 11, 2021
Catastrophic demyelinating multifocal encephalitisS Rubio-Guerra, A Massuet-Vilamajó, S Presas-Rodríguez, et al.
Neurologia|October 29, 2021
Single pseudotumour lesion, a rare debut presentation of optic neuromyelitis spectrum disorderN Zhu, S Presas-Rodríguez, F Núñez-Marín, et al.
Neurologia (Barcelona, Spain)|September 19, 2015
Myelitis: Differences between multiple sclerosis and other aetiologiesS Presas-Rodríguez, L Grau-López, J V Hervás-García, et al.
European Journal of Neurology|October 24, 2018
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trialJ V Hervás-García, L Ramió-Torrentà, L Brieva-Ruiz, et al.
Cellular & Molecular Immunology|May 7, 2021
Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapyM J Mansilla, S Presas-Rodríguez, A Teniente-Serra, et al.
Neuroimage. Clinical|April 4, 2025
Efficacy of cognitive rehabilitation in cognition and brain networks: A randomised clinical trial in patients with multiple sclerosisE Lopez-Soley, E Martinez-Heras, F Vivo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Neurologia|December 25, 2021
Catastrophic demyelinating multifocal encephalitisS Rubio-Guerra, A Massuet-Vilamajó, S Presas-Rodríguez, et al.
Neurologia|April 11, 2021
Catastrophic demyelinating multifocal encephalitisS Rubio-Guerra, A Massuet-Vilamajó, S Presas-Rodríguez, et al.
Neurologia|October 29, 2021
Single pseudotumour lesion, a rare debut presentation of optic neuromyelitis spectrum disorderN Zhu, S Presas-Rodríguez, F Núñez-Marín, et al.
Neurologia (Barcelona, Spain)|September 19, 2015
Myelitis: Differences between multiple sclerosis and other aetiologiesS Presas-Rodríguez, L Grau-López, J V Hervás-García, et al.
European Journal of Neurology|October 24, 2018
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trialJ V Hervás-García, L Ramió-Torrentà, L Brieva-Ruiz, et al.
Cellular & Molecular Immunology|May 7, 2021
Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapyM J Mansilla, S Presas-Rodríguez, A Teniente-Serra, et al.
Neuroimage. Clinical|April 4, 2025
Efficacy of cognitive rehabilitation in cognition and brain networks: A randomised clinical trial in patients with multiple sclerosisE Lopez-Soley, E Martinez-Heras, F Vivo, et al.
Pageof 1